About This EventCrown Crafts, Inc. (Nasdaq: CRWS) visits the Nasdaq MarketSite in Times Square as they kick-off attendance at the North American International Toy Fair and celebrate the relaunch of ...
As the data in Chart 2 shows, around 19.4% of all off-exchange trades occur at midpoint. However, only 0.5% are at “stale” midpoints – where the NBBO has already changed – and almost none of those are ...
About This EventPolaryx Therapeutics, Inc., (Nasdaq: PLYX), visits the Nasdaq MarketSite in Times Square.In honor of the occasion, Alex Yang, Chairman and CEO rings the Closing Bell.
Find annual and quearterly earnings data for Coinbase Global, Inc. Class A Common Stock (COIN) including earnings per share, earnings forecasts at Nasdaq.com.
About This EventNational Black Movie Association visits the Nasdaq MarketSite in Times Square.The National Black Movie Association is a nonprofit organization dedicated to celebrating, preserving, and ...
About This EventSOLV Energy (Nasdaq: MWH), a leading provider of infrastructure services to the power industry, visits the Nasdaq MarketSite in Times Square.
In 2025, the initial public offering (IPO) market continued to rebound from the 2022 and 2023 slump. For the second year in a row, markets saw more IPOs, more special purpose acquisition companies ...
About This EventOlema Pharmaceuticals, Inc. (“Olema”, or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of ...
About This EventZillow Group, Inc. (Nasdaq: Z) visits the Nasdaq MarketSite in Times Square.In honor of the occasion, Jeremy Wacksman, Zillow’s Chief Executive Officer rings the Closing Bell.
About This EventZevra Therapeutics (Nasdaq: ZVRA), a commercial-stage company focused on providing therapies for people living with rare disease, visits the Nasdaq MarketSite in Times Square.In honor ...
About This EventSpyGlass Pharma, Inc. (Nasdaq: SGP), a late-stage biopharmaceutical company dedicated to transforming the treatment paradigm for patients living with chronic eye conditions through ...
About This EventAgomAb Therapeutics NV (Nasdaq: AGMB), a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results